MBX.TO - Microbix Biosystems Inc.

Toronto - Toronto Delayed Price. Currency in CAD
0.31
0.00 (0.00%)
At close: 12:17PM EST
Stock chart is not supported by your current browser
Previous Close0.31
Open0.31
Bid0.31 x 0
Ask0.31 x 0
Day's Range0.31 - 0.31
52 Week Range0.20 - 0.40
Volume41,888
Avg. Volume33,334
Market Cap29.875M
Beta0.99
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Is Microbix Biosystems Inc’s (TSX:MBX) Balance Sheet Strong Enough To Weather A Storm?
    Simply Wall St.2 months ago

    Is Microbix Biosystems Inc’s (TSX:MBX) Balance Sheet Strong Enough To Weather A Storm?

    Investors are always looking for growth in small-cap stocks like Microbix Biosystems Inc (TSX:MBX), with a market cap of CAD CA$28.38M. However, an important fact which most ignore is: howRead More...

  • Microbix Biosystems, Inc. :MBX-CA: Earnings Analysis: Q3, 2017 By the Numbers : August 22, 2017
    Capital Cube4 months ago

    Microbix Biosystems, Inc. :MBX-CA: Earnings Analysis: Q3, 2017 By the Numbers : August 22, 2017

    Categories: Yahoo FinanceGet free summary analysis Microbix Biosystems, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Microbix Biosystems, Inc. – ProMetic Life Sciences Inc., Spectral Medical Inc, Ceapro Inc., Aeterna Zentaris Inc. and ProMIS Neurosciences Inc. (PLI-CA, EDT-CA, CZO-CA, AEZS-US and PMN-CA) that have ... Read more (Read more...)

  • Microbix Biosystems, Inc. :MBX-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 3, 2017
    Capital Cube4 months ago

    Microbix Biosystems, Inc. :MBX-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 3, 2017

    Categories: Yahoo FinanceGet free summary analysis Microbix Biosystems, Inc. reports financial results for the quarter ended March 31, 2017. Highlights Summary numbers: Revenues of CAD 2.65 million, Net Earnings of CAD 0.26 million. Gross margins widened from 47.71% to 52.34% compared to the same period last year, operating (EBITDA) margins now 16.36% from 16.85%. Change in operating ... Read more (Read more...)

  • Microbix Biosystems, Inc. :MBX-CA: Earnings Analysis: Q4, 2016 By the Numbers : January 19, 2017
    Capital Cube11 months ago

    Microbix Biosystems, Inc. :MBX-CA: Earnings Analysis: Q4, 2016 By the Numbers : January 19, 2017

    Categories: Yahoo Finance Get free summary analysis Microbix Biosystems, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Microbix Biosystems, Inc. – IBEX Technologies Inc. and Generex Biotechnology Corporation (IBT-CA and GNBT-US) that have also reported for this period. Highlights Summary numbers: Revenues of CAD 3.47 ... Read more (Read more...)